SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: AVXT RESEARCH THREAD

No earlier versions found for this Subject.


Return to AVXT RESEARCH THREAD
 
Avax, (AVXT) is fast becoming the first company with a marketable cancer vaccine.

They have a unique process that takes a piece of a patient's tumor and then allows them to develop a custom vaccine to stimulate the patient's immune system.

With a growing pipeline, in a strong segment (cancer treatment and prevention) they should experience strong growth.

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News